Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TNYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 78.08M
March 31, 2026 80.89M
December 31, 2025 100.55M
September 30, 2025 56.31M
June 30, 2025 71.67M
March 31, 2025 88.16M
December 31, 2024 61.45M
September 30, 2024 79.47M
June 30, 2024 99.30M
March 31, 2024 122.25M
December 31, 2023 104.64M
September 30, 2023 121.75M
Date Value
June 30, 2023 132.50M
March 31, 2023 147.81M
December 31, 2022 186.53M
September 30, 2022 149.45M
June 30, 2022 180.92M
March 31, 2022 210.45M
December 31, 2021 251.30M
September 30, 2021 280.46M
June 30, 2021 111.89M
March 31, 2021 128.44M
December 31, 2020 128.54M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. 437.76M
Arrowhead Pharmaceuticals, Inc. 1.602B
Oncolytics Biotech, Inc. 4.115M
Sangamo Therapeutics, Inc. 27.59M
Sarepta Therapeutics, Inc. 788.49M